NVAX
Novavax, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong buy
+71/100
Last price
11.30
▼ 1.26 (10.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
12.59
Prev close
12.56
Day high
13.33
Day low
10.88
Volume
19.41M
Market cap
$1.87B
P/E (TTM)
—
52W range
6.20 – 13.39
Day trading desk
Gap from prior close
+0.24%
Prior close 12.56
VWAP
11.68
-3.24% from price
Relative volume
3.70×
Unusually busy
Session range
22.52%
10.88 – 13.33
Position in range
17%
Near session low
ATR (14D)
0.92
8.12% of price
Prior day high
13.39
PDH
Prior day low
10.28
PDL
Bid / ask spread
—
Quote not published
Session volume
18.80M
Avg 5.09M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.62%
+2.7%
1M
+10.76%
+9.6%
3M
+21.07%
+16.5%
6M
+41.85%
+23.7%
YTD
+68.45%
+54.2%
1Y
+19.66%
+3.2%
3Y
+56.35%
-25.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NVAX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
8.33M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 18, 26 | ALTON GREGG H Director |
— | 18.88K | — | Direct |
| Jun 18, 26 | KING RACHEL K Director |
— | 18.88K | — | Direct |
| Jun 18, 26 | MOTT DAVID M Director |
— | 18.88K | — | Direct |
| Jun 18, 26 | MCGLYNN MARGARET G Director |
— | 18.88K | — | Direct |
| Jun 18, 26 | DOUGLAS RICHARD H Director |
— | 18.88K | — | Direct |
| Jun 18, 26 | RODGERS RICHARD J. Director |
— | 18.88K | — | Direct |
| Apr 24, 26 | NEWTON CHARLES W. Director |
— | 9.52K | — | Direct |
| Mar 10, 26 | SHIVER JOHN W. PH.D. Director |
— | 7.95K | — | Direct |
| Mar 6, 26 | KELLY JAMES PATRICK Chief Financial Officer |
— | 12.22K | — | Direct |
| Mar 3, 26 | CASEY MARK J Officer |
— | 37.50K | — | Direct |
| Mar 3, 26 | KELLY JAMES PATRICK Chief Financial Officer |
— | 43.17K | — | Direct |
| Mar 3, 26 | JACOBS JOHN C Chief Executive Officer |
— | 150.17K | — | Direct |
| Mar 3, 26 | O'HARA ELAINE Officer |
— | 56.33K | — | Direct |
| Mar 3, 26 | DRAGHIA-AKLI RUXANDRA Officer |
— | 26.67K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALTON GREGG H |
Director | 47.69K | Conversion of Exercise of derivative security |
CASEY MARK J |
Officer | 90.07K | Conversion of Exercise of derivative security |
DOUGLAS RICHARD H |
Director | 73.22K | Conversion of Exercise of derivative security |
JACOBS JOHN C |
Chief Executive Officer | 225.68K | Conversion of Exercise of derivative security |
KELLY JAMES PATRICK |
Chief Financial Officer | 130.60K | Conversion of Exercise of derivative security |
MOTT DAVID M |
Director | 79.77K | Conversion of Exercise of derivative security |
O'HARA ELAINE |
Officer | 134.64K | Conversion of Exercise of derivative security |
RODGERS RICHARD J. |
Director | 47.37K | Conversion of Exercise of derivative security |
TRIZZINO JOHN J |
President | 68.06K | Conversion of Exercise of derivative security |
YOUNG JAMES FRANCIS |
Director | 51.76K | Sale |
Fundamentals
Market cap$1.87B
Enterprise value$1.45B
Revenue (TTM)$413.80M
Gross profit$-10.58M
EBITDA$-101.55M
Net income$-247.73M
EPS (TTM)$-1.58
Free cash flow$153.39M
Total cash$719.34M
Total debt$297.32M
Book value / share$-1.16
Shares outstanding164.95M
Float142.58M
Short % of float30.43%
Dividend yield0.00%
Beta (5Y)2.44
Valuation & profitability ratios
Trailing P/E—
Forward P/E-18.44
PEG ratio1.32
Price / sales—
Price / book—
EV / revenue3.49
EV / EBITDA-14.23
Gross margin-2.56%
Operating margin-89.61%
Profit margin-59.87%
Return on equity—
Return on assets-6.51%
Debt / equity—
Current ratio2.33
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.12B | $682.16M | $556.38M | $1.60B | +64.7% |
| Operating revenue | $1.12B | $682.16M | $556.38M | $1.60B | +64.7% |
| Cost of revenue | $73.04M | $202.74M | $343.77M | $902.64M | -64.0% |
| Gross profit | $1.05B | $479.42M | $212.61M | $696.31M | +119.1% |
| Research & development | $342.32M | $391.17M | $737.50M | $1.24B | -12.5% |
| Selling, general & admin | $157.48M | $337.19M | $468.95M | $488.69M | -53.3% |
| Total operating expense | $499.80M | $728.35M | $779.13M | $1.34B | -31.4% |
| Operating income | $550.64M | -$248.93M | -$566.51M | -$644.74M | +321.2% |
| Net interest income | -$22.55M | -$20.07M | -$14.42M | -$19.88M | -12.3% |
| Pre-tax income | $442.17M | -$176.62M | -$543.03M | -$653.65M | +350.4% |
| Tax provision | $1.86M | $10.88M | $2.03M | $4.29M | -82.9% |
| Net income | $440.30M | -$187.50M | -$545.06M | -$657.94M | +334.8% |
| Net income to common | $440.30M | -$187.50M | -$545.06M | -$657.94M | +334.8% |
| Basic EPS | 2.72 | -1.23 | -5.41 | -8.42 | +321.1% |
| Diluted EPS | 2.58 | -1.23 | -5.41 | -8.42 | +309.8% |
| EBIT | $464.71M | -$156.54M | -$528.62M | -$633.77M | +396.9% |
| EBITDA | $492.33M | -$108.04M | -$487.39M | -$604.71M | +555.7% |
| Basic shares | 161.99M | 152.19M | 100.77M | 78.18M | +6.4% |
| Diluted shares | 173.10M | 152.19M | 100.77M | 78.18M | +13.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $240.63M | $530.23M | $568.50M | $1.34B | -54.6% |
| Cash & short-term investments | $735.08M | $923.12M | $568.50M | $1.34B | -20.4% |
| Accounts receivable | $106.45M | $108.28M | $297.24M | $82.38M | -1.7% |
| Inventory | $11.54M | $8.75M | $41.70M | $36.68M | +32.0% |
| Total current assets | $978.28M | $1.13B | $1.14B | $1.70B | -13.3% |
| Property, plant & equipment | $67.70M | $300.00M | $490.99M | $400.49M | -77.4% |
| Goodwill & intangibles | $113.46M | $107.48M | $127.45M | $126.33M | +5.6% |
| Total assets | $1.18B | $1.56B | $1.80B | $2.26B | -24.6% |
| Total current liabilities | $459.95M | $1.15B | $1.64B | $2.46B | -60.2% |
| Current debt | — | — | — | $324.88M | — |
| Long-term debt | $244.21M | $169.68M | $168.02M | $166.47M | +43.9% |
| Total debt | $248.81M | $230.42M | $229.08M | $549.78M | +8.0% |
| Total liabilities | $1.30B | $2.18B | $2.51B | $2.89B | -40.3% |
| Retained earnings | -$4.57B | -$5.01B | -$4.82B | -$4.28B | +8.8% |
| Shareholder equity | -$127.75M | -$623.84M | -$716.93M | -$634.08M | +79.5% |
| Working capital | $518.33M | -$25.47M | -$491.25M | -$756.55M | +2,134.7% |
| Net tangible assets | -$241.22M | -$731.32M | -$844.38M | -$760.41M | +67.0% |
| Shares issued | 164.97M | 161.94M | 140.51M | 86.81M | +1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $440.30M | -$187.50M | -$545.06M | -$657.94M | +334.8% |
| Depreciation & amortisation | $27.61M | $48.50M | $41.23M | $29.05M | -43.1% |
| Stock-based compensation | $36.02M | $48.15M | $85.36M | $130.30M | -25.2% |
| Change in working capital | -$887.71M | $48.48M | -$376.84M | -$361.15M | -1,931.0% |
| Operating cash flow | -$244.63M | -$87.26M | -$713.97M | -$415.94M | -180.3% |
| Capital expenditure | -$6.39M | -$14.64M | -$58.81M | -$92.98M | +56.4% |
| Investing cash flow | -$78.27M | -$204.04M | -$58.81M | -$92.98M | +61.6% |
| Financing cash flow | $27.74M | $260.58M | $4.47M | $324.99M | -89.4% |
| Free cash flow | -$251.02M | -$101.90M | -$772.77M | -$508.92M | -146.3% |
| End cash position | $256.05M | $545.29M | $583.81M | $1.35B | -53.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $56.70M | $139.51M | $147.14M | $70.44M | $239.24M | -59.4% |
| Operating revenue | $56.70M | $139.51M | $147.14M | $70.44M | $239.24M | -59.4% |
| Cost of revenue | $14.25M | $30.70M | $22.10M | $21.50M | $15.32M | -53.6% |
| Gross profit | $42.45M | $108.82M | $125.03M | $48.95M | $223.91M | -61.0% |
| Research & development | $70.69M | $95.47M | $75.88M | $98.27M | $79.23M | -26.0% |
| Selling, general & admin | $26.66M | $28.78M | $34.12M | $31.66M | $43.61M | -7.3% |
| Total operating expense | $97.36M | $124.25M | $110.00M | $129.93M | $122.84M | -21.6% |
| Operating income | -$54.91M | -$15.43M | $15.04M | -$80.98M | $101.07M | -255.8% |
| Net interest income | -$5.69M | -$4.90M | -$5.82M | -$5.48M | -$5.52M | -16.1% |
| Pre-tax income | -$51.68M | -$8.51M | $17.90M | -$203.04M | $107.45M | -507.5% |
| Tax provision | $1.71M | $985.00K | $376.00K | -$657.00K | $946.00K | +73.7% |
| Net income | -$53.39M | -$9.49M | $17.53M | -$202.38M | $106.51M | -462.5% |
| Net income to common | -$53.39M | -$9.49M | $17.53M | -$202.38M | $106.51M | -462.5% |
| Basic EPS | -0.32 | -0.06 | 0.11 | -1.25 | 0.66 | -433.3% |
| Diluted EPS | -0.32 | -0.06 | 0.11 | -1.25 | 0.62 | -433.3% |
| EBIT | -$45.99M | -$3.60M | $23.73M | -$197.55M | $112.97M | -1,175.6% |
| EBITDA | -$42.93M | -$543.00K | $28.85M | -$190.97M | $120.53M | -7,806.3% |
| Basic shares | 164.57M | 163.28M | 162.53M | 162.35M | 162.02M | +0.8% |
| Diluted shares | 164.57M | 163.28M | 165.18M | 162.35M | 177.22M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $191.46M | $228.36M | $240.63M | $268.02M | $253.74M | -16.2% |
| Cash & short-term investments | $719.34M | $790.33M | $735.08M | $762.89M | $612.30M | -9.0% |
| Accounts receivable | $18.74M | $23.31M | $106.45M | $34.17M | $226.40M | -19.6% |
| Inventory | $10.01M | $11.46M | $11.54M | $13.51M | $10.24M | -12.7% |
| Total current assets | $771.10M | $850.82M | $978.28M | $974.59M | $919.51M | -9.4% |
| Property, plant & equipment | $57.98M | $63.51M | $67.70M | $72.99M | $282.69M | -8.7% |
| Goodwill & intangibles | $112.54M | $112.89M | $113.46M | $113.08M | $112.96M | -0.3% |
| Total assets | $955.58M | $1.04B | $1.18B | $1.18B | $1.34B | -8.4% |
| Total current liabilities | $330.57M | $342.46M | $459.95M | $429.87M | $389.14M | -3.5% |
| Long-term debt | $291.49M | $291.04M | $244.21M | $243.84M | $170.57M | +0.2% |
| Total debt | $297.32M | $295.06M | $248.81M | $251.14M | $228.49M | +0.8% |
| Total liabilities | $1.15B | $1.19B | $1.30B | $1.34B | $1.30B | -3.5% |
| Retained earnings | -$4.63B | -$4.58B | -$4.57B | -$4.59B | -$4.38B | -1.2% |
| Shareholder equity | -$190.71M | -$144.76M | -$127.75M | -$156.67M | $37.63M | -31.7% |
| Working capital | $440.52M | $508.36M | $518.33M | $544.72M | $530.37M | -13.3% |
| Net tangible assets | -$303.25M | -$257.65M | -$241.22M | -$269.75M | -$75.33M | -17.7% |
| Shares issued | 164.82M | 167.77M | 164.97M | 164.82M | 164.48M | -1.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$53.39M | -$9.49M | $17.53M | -$202.38M | $106.51M | -462.5% |
| Depreciation & amortisation | $3.06M | $3.06M | $5.13M | $6.58M | $7.56M | -0.2% |
| Stock-based compensation | $8.09M | $7.72M | $7.97M | $8.55M | $9.21M | +4.7% |
| Change in working capital | -$33.25M | -$25.01M | -$73.70M | $165.93M | -$240.33M | -32.9% |
| Operating cash flow | -$72.81M | -$32.42M | -$39.48M | $107.80M | -$127.46M | -124.6% |
| Capital expenditure | -$588.00K | -$1.27M | -$2.25M | -$2.02M | -$527.00K | +53.7% |
| Investing cash flow | $34.90M | -$28.36M | $20.48M | -$136.53M | $111.10M | +223.0% |
| Financing cash flow | $1.20M | $37.67M | -$6.60M | $42.44M | -$1.04M | -96.8% |
| Free cash flow | -$73.39M | -$33.69M | -$41.72M | $105.79M | -$127.99M | -117.8% |
| End cash position | $196.04M | $232.93M | $256.05M | $283.36M | $268.98M | -15.8% |
Options analytics
Put / call volume
0.43
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
3.00
-73.5% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
+25.0%
Puts bid over calls
Call volume
13.00K
Contracts, this expiry
Put volume
5.55K
Contracts, this expiry
Heaviest call OI
3.00
0 contracts
Heaviest put OI
3.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.38 | -0.32 | +16.6% |
| Mar 2026 | -0.24 | -0.06 | +75.2% |
| Dec 2025 | -0.49 | 0.11 | +122.5% |
| Sep 2025 | -1.17 | -1.25 | -7.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.18 | 8 | $84.75M | +20.3% |
| Next quarter | -0.11 | 8 | $95.92M | -34.8% |
| Current year | -0.64 | 9 | $377.29M | -66.4% |
| Next year | -0.12 | 9 | $292.86M | -22.4% |
Analyst targets & ownership
Mean target$14.00
High target$25.00
Low target$7.00
Implied upside23.91%
Analyst count9
ConsensusBUY
Strong buy / Buy0 / 5
Hold1
Sell / Strong sell1 / 2
Held by insiders5.05%
Held by institutions68.72%
Institutions holding354
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
10.92
+3.53% from price
SMA 20
10.36
+9.25% from price
SMA 50
9.27
+22.06% from price
SMA 100
9.20
+22.87% from price
SMA 200
8.94
+26.61% from price
EMA 12
10.87
+3.97% from price
EMA 26
10.31
+9.57% from price
EMA 50
9.77
+15.69% from price
RSI (14)
60.0
Neutral
MACD (12,26,9)
0.56
Hist 0.08
ATR (14)
0.92
8.11% of price
Realised vol 30D
76.4%
Annualised
Bollinger upper
11.92
20, 2σ
Bollinger lower
8.80
20, 2σ
50 / 200 cross
Golden
9.27 vs 8.94
Trend bias
Above 200
+26.61%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.82
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
76.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-34.6%
Peak to trough
Max drawdown 5Y
-98.3%
Peak to trough
ATR 14
0.92
8.11% of price
Beta (reported)
2.44
5Y monthly, from filing
Short interest
Shares short
49.88M
Prior 47.49M
Change vs prior
+5.0%
Shorts adding
% of float
30.43%
Heavily shorted
% of shares out
30.24%
Against total outstanding
Days to cover
8.9
Crowded exit
Float
142.58M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 11, 26 | BTIG | MAINTAINED | Buy | Buy |
| May 6, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Feb 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 20, 26 | BTIG | MAINTAINED | Buy | Buy |
| Nov 18, 25 | JP Morgan | MAINTAINED | Underweight | Underweight |
| Nov 10, 25 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Nov 4, 25 | TD Cowen | MAINTAINED | Hold | Hold |
| Oct 24, 25 | Cantor Fitzgerald | INITIATED | — | Overweight |
| Oct 23, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 20, 25 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| Jul 22, 25 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jun 17, 25 | Citigroup | INITIATED | — | Sell |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateMay 10, 2019
Last split1:20
Split dateMay 10, 2019
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-23
Corporate Changes & Voting Matters
8-K · 2026-05-06
Annual Report to Shareholders
ARS · 2026-04-27
Periodic Financial Reports
10-K · 2026-02-26
Corporate Changes & Voting Matters
8-K · 2026-01-20
Corporate Changes & Voting Matters
8-K · 2026-01-12
Corporate Changes & Voting Matters
8-K · 2025-11-06
Headlines
Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare.
Barrons.com · 9h ago
Novavax, Moderna stocks fall after WHO calls plague risk 'low'
Yahoo Finance · 9h ago
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why
Zacks · 9h ago
Novavax Sinks 12% as WHO Calls Plague Risk “Very Low”
TIKR · 10h ago
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna and Pfizer Inch Higher
24/7 Wall St. · 16h ago
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?
Zacks · 23h ago
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
Stocktwits · 1d ago
NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test
Stocktwits · 1d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.